Physician Data Query

Last uploaded: August 27, 2019
Preferred Name

resveratrol formulation SRT501
Synonyms

SRT501

Definitions

A proprietary formulation of resveratrol, a polyphenolic phytoalexin derived from grapes and other food products with potential antioxidant, anti-obesity, antidiabetic and chemopreventive activities. Resveratrol may activate sirtuin subtype 1 (SIRT-1). SIRT1 activation has been reported to inhibit tumorigenesis and tumor cell proliferation.SIRT-1 is a member of the silent information regulator 2 (SIR2) (or sirtuin) family of enzymes that plays an important role in mitochondrial activity and acts as a protein deacetylase. SIRT1 appears to be involved in the regulation of numerous transcription factors such as Nf-kB and p53. Check for "https://www.cancer.gov/about-cancer/treatment/clinical-trials/intervention/C85484" active clinical trials using this agent. ("http://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C85484" NCI Thesaurus)

ID

http://purl.bioontology.org/ontology/PDQ/CDR0000648245

altLabel

SRT501

cui

C2002402

DATE FIRST PUBLISHED

2009-06-25

Date last modified

2010-02-11

definition

A proprietary formulation of resveratrol, a polyphenolic phytoalexin derived from grapes and other food products with potential antioxidant, anti-obesity, antidiabetic and chemopreventive activities. Resveratrol may activate sirtuin subtype 1 (SIRT-1). SIRT1 activation has been reported to inhibit tumorigenesis and tumor cell proliferation.SIRT-1 is a member of the silent information regulator 2 (SIR2) (or sirtuin) family of enzymes that plays an important role in mitochondrial activity and acts as a protein deacetylase. SIRT1 appears to be involved in the regulation of numerous transcription factors such as Nf-kB and p53. Check for "https://www.cancer.gov/about-cancer/treatment/clinical-trials/intervention/C85484" active clinical trials using this agent. ("http://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C85484" NCI Thesaurus)

NCI ID

C85484

notation

CDR0000648245

ORIG STY

Drug/agent

prefLabel

resveratrol formulation SRT501

tui

T109

T121

Delete Subject Author Type Created
No notes to display